Sonoma Pharmaceuticals (SNOA) SEC Filings & 10K Form

$0.16
0.00 (0.00%)
(As of 04/23/2024 ET)

Recent Sonoma Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/09/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:30 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
3:47 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:23 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:24 PM
DVONCH JEROME J (Reporting)
Sonoma Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:25 PM
Dal Poggetto John (Reporting)
Sonoma Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:25 PM
Sonoma Pharmaceuticals (Issuer)
Thornton Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:26 PM
Sonoma Pharmaceuticals (Issuer)
Trombly Amy Moss (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
4:30 PM
Sonoma Pharmaceuticals (Filer)
Form 424B3
11/22/2023
3:30 PM
Sonoma Pharmaceuticals (Filer)
Form 424B5
11/20/2023
11:15 PM
Sonoma Pharmaceuticals (Filer)
Form EFFECT
10/30/2023
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 424B4
10/26/2023
11:15 PM
Sonoma Pharmaceuticals (Filer)
Form EFFECT
10/13/2023
4:19 PM
Sonoma Pharmaceuticals (Filer)
Form S-1/A
10/11/2023
3:30 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K/A
10/11/2023
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
3:41 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
3:30 PM
Sonoma Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/14/2023
4:00 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
4:00 PM
Sonoma Pharmaceuticals (Issuer)
Thornton Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
4:00 PM
Sonoma Pharmaceuticals (Issuer)
Trombly Amy Moss (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:15 PM
Sonoma Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/10/2023
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SNOA) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners